The targeted cancer therapies for HCC usually employ receptors like asialoglycoprotein receptor (ASGPR) [48], glycyrrhetinic acid receptor [49], transferrin receptor [50], somatostatin receptor [51], folate receptor [52], retinoic acid receptors [53] or epidermal growth factor receptor [54] etc. to deliver drugs to liver tumors. Here, TFRC is linked to cancer.